推荐产品
等級
pharmaceutical primary standard
API 家族
tribenoside
製造商／商標名
EDQM
應用
pharmaceutical (small molecule)
格式
neat
運輸包裝
wet ice
儲存溫度
−20°C
InChI
1S/C29H34O6/c1-2-32-29-26(30)28(34-20-24-16-10-5-11-17-24)27(35-29)25(33-19-23-14-8-4-9-15-23)21-31-18-22-12-6-3-7-13-22/h3-17,25-30H,2,18-21H2,1H3/t25?,26-,27-,28-,29?/m1/s1
InChI 密鑰
ULLNJSBQMBKOJH-NUZMXOBKSA-N
一般說明
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
應用
Tribenoside EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
包裝
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
其他說明
Sales restrictions may apply.
儲存類別代碼
11 - Combustible Solids
閃點（°F）
Not applicable
閃點（°C）
Not applicable
Glyvenol therapy in varicose veins an evaluation of its effectiveness.
I Kakande
East African medical journal, 58(7), 532-538 (1981-07-01)
D A Kalbhen et al.
The Journal of rheumatology, 10(2), 267-281 (1983-04-01)
Experiments in adult hens with chemically induced osteoarthrosis or osteoarthritis (OA) of the knee joint have shown that daily treatment with tribenoside (Glyvenol) in single oral doses of 50 mg/kg or 150 mg/kg markedly reduced the intensity and frequency of
Tamás Kubicsek et al.
Reproductive toxicology (Elmsford, N.Y.), 31(4), 464-469 (2010-12-25)
Tribenoside is used for the treatment of haemorrhoids and varicose veins, frequently in pregnant women as well, but published data regarding its possible teratogenic effect are not available. Thus the risk of congenital abnormalities (CAs) was estimated in cases of
[Test of potential antiarthritic drugs on spontaneous arthritis of mice].
G Wilhelmi et al.
Zeitschrift fur Rheumatologie, 42(4), 203-205 (1983-07-01)
L A Chaĭka et al.
Farmakologiia i toksikologiia, 44(1), 74-77 (1981-01-01)
A study was made on the mechanism of action of the antivaricose agent tribenol (ethyl-3,5,6-tri-O-benzyl-D-glucofuranozide; glivenol) on the activity of hydroxyreductase on the Krebs cycle and glycolysis during occlusion of the femoral vein and its inflammation in rats. It was
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门